Morton Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$968K Buy
7,531
+598
+9% +$70K 0.13% 51
2026
Q1
$834K Sell
6,933
-304
-4% -$35.1K 0.12% 53
2025
Q4
$762K Buy
7,237
+192
+3% +$18K 0.12% 53
2025
Q3
$591K Buy
7,045
+42
+0.6% +$3.46K 0.1% 64
2025
Q2
$554K Sell
7,003
-423
-6% -$33.6K 0.1% 66
2025
Q1
$667K Buy
7,426
+67
+0.9% +$6.26K 0.13% 56
2024
Q4
$732K Sell
7,359
-8
-0.1% -$825 0.14% 54
2024
Q3
$837K Buy
7,367
+578
+9% +$68.7K 0.16% 48
2024
Q2
$841K Buy
6,789
+30
+0.4% +$3.86K 0.2% 46
2024
Q1
$892K Buy
6,759
+211
+3% +$26K 0.24% 41
2023
Q4
$714K Sell
6,548
-1,081
-14% -$112K 0.21% 45
2023
Q3
$785K Buy
7,629
+100
+1% +$10.8K 0.28% 36
2023
Q2
$869K Buy
7,529
+1,000
+15% +$114K 0.3% 34
2023
Q1
$695K Buy
6,529
+4
+0.1% +$432 0.25% 42
2022
Q4
$724K Sell
6,525
-503
-7% -$51.4K 0.28% 35
2022
Q3
$605K Sell
7,028
-445
-6% -$39.7K 0.28% 35
2022
Q2
$681K Buy
7,473
+45
+0.6% +$3.99K 0.3% 33
2022
Q1
$609K Buy
7,428
+206
+3% +$16.2K 0.25% 39
2021
Q4
$553K Buy
+7,222
New +$575K 0.22% 46

Other funds holding MRK

Morton Capital Management's MRK Position: Q2 2026 in Review

Morton Capital Management increased its Merck (MRK) stake by 8.6% in Q2 2026, buying an estimated $70K and bringing the position to 7,531 shares worth $968K. The position accounts for 0.13% of the portfolio, ranked #51.

Morton Capital Management first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Morton Capital Management held 7,531 shares of Merck worth $968K as of Q2 2026.
  • Morton Capital Management bought 598 Merck shares in Q2 2026, an estimated $70K.
  • Merck made up 0.13% of Morton Capital Management's portfolio in Q2 2026, its #51 holding.
  • Morton Capital Management first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Morton Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.